相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protein-loaded soluble and nanoparticulate formulations of ionic polyphosphazenes and their interactions on molecular and cellular levels
Alexander K. Andrianov et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
HPV16 L1 diversity and its potential impact on the vaccination-induced immunity
Aissam El Aliani et al.
GENE (2020)
Supramolecular Assembly of Toll-like Receptor 7/8 Agonist into Multimeric Water-Soluble Constructs Enables Superior Immune Stimulation In Vitro and In Vivo
Alexander K. Andrianov et al.
ACS APPLIED BIO MATERIALS (2020)
New Family of Water-Soluble Sulfo-Fluoro Polyphosphazenes and Their Assembly within Hemocompatible Nanocoatings
Victoria Albright et al.
ACS APPLIED BIO MATERIALS (2019)
Biocompatible Nanocoatings of Fluorinated Polyphosphazenes through Aqueous Assembly
Victor Selin et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Roles of Fc Domain and Exudation in L2 Antibody-Mediated Protection against Human Papillomavirus
Joshua W. Wang et al.
JOURNAL OF VIROLOGY (2018)
Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses
Marija Vujadinovic et al.
VACCINE (2018)
Aluminum Adjuvant-Containing Vaccines in the Context of the Hygiene Hypothesis: A Risk Factor for Eosinophilia and Allergy in a Genetically Susceptible Subpopulation?
Todd D. Terhune et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)
A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice
Farhad Motavalli Khiavi et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Recent advances in experimental polyphosphazene adjuvants and their mechanisms of action
Royford Magiri et al.
CELL AND TISSUE RESEARCH (2018)
Polymer Structure and Conformation Alter the Antigenicity of Virus-like Particle-Polymer Conjugates
Parker W. Lee et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
PCPP-Adjuvanted Respiratory Syncytial Virus (RSV) sF Subunit Vaccine: Self-Assembled Supramolecular Complexes Enable Enhanced Immunogenicity and Protection
Corinne Cayatte et al.
MOLECULAR PHARMACEUTICS (2017)
Molecular-Level Interactions of Polyphosphazene Immunoadjuvants and Their Potential Role in Antigen Presentation and Cell Stimulation
Alexander K. Andrianov et al.
BIOMACROMOLECULES (2016)
The Developmental History of IgE and IgG4 Antibodies in Relation to Atopy, Eosinophilic Esophagitis, and the Modified TH2 Response
Rob C. Aalberse et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2016)
Progress and prospects for L2-based human papillomavirus vaccines
Rosie T. Jiang et al.
EXPERT REVIEW OF VACCINES (2016)
Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles
Mathieu Boxus et al.
JOURNAL OF VIROLOGY (2016)
Different human vaccine adjuvants promote distinct antigenin-dependent immunological signatures tailored to different pathogens
Niels Peter H. Knudsen et al.
SCIENTIFIC REPORTS (2016)
Self-assembly of polyphosphazene immunoadjuvant with polyethylene oxide) enables advanced nanoscale delivery modalities and regulated pH-dependent cellular membrane activity
Alexander K. Andrianov et al.
HELIYON (2016)
Development of a highly thermostable, adjuvanted human papillomavirus vaccine
Kimberly J. Hassett et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes
Bradford S. Powell et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2015)
The effect of stable macromolecular complexes of ionic polyphosphazene on HIV Gag antigen and on activation of human dendritic cells and presentation to T-cells
Christine D. Palmer et al.
BIOMATERIALS (2014)
A Vaccine of L2 Epitope Repeats Fused with a Modified IgG1 Fc Induced Cross-Neutralizing Antibodies and Protective Immunity against Divergent Human Papillomavirus Types
Xue Chen et al.
PLOS ONE (2014)
The adjuvant PCEP induces recruitment of myeloid and lymphoid cells at the injection site and draining lymph node
Sunita Awate et al.
VACCINE (2014)
Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies
Joshua W. Wang et al.
VIROLOGY (2014)
Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
Christina Schellenbacher et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Phylogenetic Considerations in Designing a Broadly Protective Multimeric L2 Vaccine
Subhashini Jagu et al.
JOURNAL OF VIROLOGY (2013)
IgG subclass profiles in normal human sera of antibodies specific to five kinds of microbial antigens
Astrid Hjelholt et al.
PATHOGENS AND DISEASE (2013)
Mechanisms of action of adjuvants
Sunita Awate et al.
FRONTIERS IN IMMUNOLOGY (2013)
Activation of adjuvant core response genes by the novel adjuvant PCEP
Sunita Awate et al.
MOLECULAR IMMUNOLOGY (2012)
Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate
Karen Nieto et al.
PLOS ONE (2012)
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
Beatriz Serrano et al.
INFECTIOUS AGENTS AND CANCER (2012)
PCPP-Formulated H5N1 Influenza Vaccine Displays Improved Stability and Dose-Sparing Effect in Lethal Challenge Studies
Alexander K. Andrianov et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis
Srinivas Garlapati et al.
VACCINE (2011)
The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies
Ivonne Rubio et al.
VIROLOGY (2011)
T helper 2 biased de novo immune response to Keyhole Limpet Hemocyanin in humans
D. Spazierer et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines
Christina Schellenbacher et al.
JOURNAL OF VIROLOGY (2009)
The cell biology of cross-presentation and the role of dendritic cell subsets
Ming-Lee Lin et al.
IMMUNOLOGY AND CELL BIOLOGY (2008)
Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice
Claudia Istrate et al.
VACCINE (2008)
Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen
George Mutwiri et al.
VACCINE (2008)
A protective and broadly cross-neutralizing epitope of human papillomavirus L2
Ratish Gambhira et al.
JOURNAL OF VIROLOGY (2007)
Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens
George Mutwiri et al.
VACCINE (2007)
Synthesis, properties, and biological activity of poly[di(sodium carboxylatoethylphenoxy)phosphazene]
AK Andrianov et al.
BIOMACROMOLECULES (2006)
Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles
H Shen et al.
IMMUNOLOGY (2006)
Polyphosphazene polyelectrolytes: A link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity
AK Andrianov et al.
BIOMACROMOLECULES (2005)
Differential cytosolic delivery and presentation of antigen by listeriolysin O-liposomes to macrophages and dendritic cells
Ethan M. Stier et al.
MOLECULAR PHARMACEUTICS (2005)
Membrane-destabilizing polyanions: interaction with lipid bilayers and endosomal escape of biomacromolecules
MA Yessine et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Synthesis and biologically relevant properties of polyphosphazene polyacids
AK Andrianov et al.
BIOMACROMOLECULES (2004)
Endosomolysis by masking of a membrane-active agent (EMMA) for cytoplasmic release of macromolecules
DB Rozema et al.
BIOCONJUGATE CHEMISTRY (2003)
Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes
RBS Roden et al.
VIROLOGY (2000)
Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16
XJS Chen et al.
MOLECULAR CELL (2000)
分享论文
